Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (551-560 of 759) with videos related to

Pageof 76
Sort By:
Cancer Medicine|October 6, 2020
Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatmentIuliana Vaxman, Abdullah S Al Saleh, Shaji Kumar, et al.
JCO Oncology Practice|May 17, 2022
Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard CareSurbhi Sidana, Cristine Allmer, Melissa C Larson, et al.
American Journal of Hematology|August 11, 2016
N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myelomaPaolo Milani, S Vincent Rajkumar, Giampaolo Merlini, et al.
Blood Advances|July 9, 2021
Prognostic impact of posttransplant FDG PET/CT scan in multiple myelomaMarcella Kaddoura, David Dingli, Francis K Buadi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 2, 2012
Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseasesNelson Leung, Morie Gertz, Robert A Kyle, et al.
Orphanet Journal of Rare Diseases|November 10, 2023
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Luca Gentile, Teresa Coelho, Angela Dispenzieri, et al.
British Journal of Haematology|February 16, 2019
Substratification of patients with newly diagnosed standard-risk multiple myelomaMoritz Binder, S Vincent Rajkumar, Rhett P Ketterling, et al.
Blood Advances|April 12, 2022
Outcomes after biochemical or clinical progression in patients with multiple myelomaSarah Goldman-Mazur, Alissa Visram, Prashant Kapoor, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 8, 2025
Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damageBrian C Netzel, M Cristine Charlesworth, Kenneth L Johnson, et al.
Blood|May 28, 2005
A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUSWee Joo Chng, Scott A Van Wier, Gregory J Ahmann, et al.
Pageof 76

Showing results (551-560 of 759) with videos related to

Sort By:
Pageof 76
Cancer Medicine|October 6, 2020
Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatmentIuliana Vaxman, Abdullah S Al Saleh, Shaji Kumar, et al.
JCO Oncology Practice|May 17, 2022
Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard CareSurbhi Sidana, Cristine Allmer, Melissa C Larson, et al.
American Journal of Hematology|August 11, 2016
N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myelomaPaolo Milani, S Vincent Rajkumar, Giampaolo Merlini, et al.
Blood Advances|July 9, 2021
Prognostic impact of posttransplant FDG PET/CT scan in multiple myelomaMarcella Kaddoura, David Dingli, Francis K Buadi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 2, 2012
Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseasesNelson Leung, Morie Gertz, Robert A Kyle, et al.
Orphanet Journal of Rare Diseases|November 10, 2023
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Luca Gentile, Teresa Coelho, Angela Dispenzieri, et al.
British Journal of Haematology|February 16, 2019
Substratification of patients with newly diagnosed standard-risk multiple myelomaMoritz Binder, S Vincent Rajkumar, Rhett P Ketterling, et al.
Blood Advances|April 12, 2022
Outcomes after biochemical or clinical progression in patients with multiple myelomaSarah Goldman-Mazur, Alissa Visram, Prashant Kapoor, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 8, 2025
Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damageBrian C Netzel, M Cristine Charlesworth, Kenneth L Johnson, et al.
Blood|May 28, 2005
A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUSWee Joo Chng, Scott A Van Wier, Gregory J Ahmann, et al.
Pageof 76